Hospitalization for Charcot neuroarthropathy in diabetes: A population study in Italy
Roberto Anichini1, Laura Policardo2, Flavia Lucia Lombardo3
1Diabetes Unit and Diabetes Foot Unit, San Jacopo Hospital, USL Centro-Toscana, Pistoia, Italy.
Insights
Charcot neuroarthropathy (CN) is infrequent in diabetic populations in Italy, with declining incidence in Tuscany. CN patients face higher risks of amputation and infection but similar revascularization needs compared to non-Charcot diabetic foot patients.
Area of Science:
- Epidemiology
- Diabetology
- Vascular Surgery
Background:
- Charcot neuroarthropathy (CN) is a severe complication of diabetic neuropathy.
- Understanding CN's epidemiological trends and its impact on lower limb procedures is crucial for patient management.
Purpose of the Study:
- To analyze hospitalization and incidence rates of Charcot neuroarthropathy (CN) in Italy and Tuscany.
- To investigate the association of CN with lower limb amputations and revascularizations in diabetic patients.
Main Methods:
- Retrospective analysis of hospitalizations for CN (ICD-9-CM codes 7130, 7135, 7138) in diabetic populations.
- Evaluation of amputation, revascularization, peripheral vascular disease, and infection rates between 2003-2013 (Italy) and 2008-2015 (Tuscany).
Main Results:
- CN hospitalizations were infrequent, with incidence rates per 100,000 diabetic patients ranging from 11-14 in Italy and declining to 7 in Tuscany.
- CN patients were younger, had longer hospital stays, and significantly higher rates of amputation and infection compared to non-Charcot diabetic foot patients.
- Revascularization rates were similar between CN and non-Charcot diabetic foot patients.
Conclusions:
- Charcot neuroarthropathy affects a small percentage of diabetic patients, with stable incidence in Italy and a recent decline in Tuscany.
- CN is linked to younger age, prolonged hospitalization, and increased risk of amputations and infections.
- The need for revascularization in CN patients is comparable to those with non-Charcot diabetic foot.
Aims:
To provide data on hospitalization and incidence rates of Charcot neuroarthropathy (CN) and its relation to lower limbs' amputations/revascularizations in population with diabetes of Italy as well as of one of its regions (Tuscany).
Methods:
Hospitalizations with CN diagnosis (codes ICD-9-CM: 7130, 7135, 7138) have been recorded in people with diabetes over years 2003-2013 in Italy and 2008-2015 in Tuscany. Amputations, peripheral vascular disease, revascularizations and infections were likewise evaluated.
Results:
Between 2003 and 2013 CN hospitalizations were very infrequent in Italy ranging between 14×100,000 and 11×100,000 patients with diabetes. In Tuscany they declined to a minimum of 7×100,000 patients in 2015, after a previous increase to a maximum of 22×100,000 (p=NS for both). Yearly CN incidence remained constant in Italy, declining in Tuscany to a minimum of 3.4×100,000 diabetic patients in 2015 (p=0.047). CN patients were younger and with longer length of hospital stay than those with non-Charcot diabetic foot (p<0.05 for both). Amputation and infection rates were manifold higher in CN patients than in those with non-Charcot diabetic foot, while the revascularization rate was similar in both.
Conclusions:
Over last decade, in Italy and Tuscany yearly CN incidence and hospitalization rates concerned only a small percentage of patients, remaining constant over years and declining in Tuscany in the last couple of years. CN was significantly associated to younger age, longer hospital stay and greater risk of amputations and infections while the need of revascularization was similar to that of non-Charcot diabetic foot.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Diabetes: Symptoms, Diagnosis, and Complications


